To test whether pharmacological inhibition of perforin-1 in vivo can influence the course of T cell-mediated hepatitis, we treated AdGOL-infected mice that received OT-I T cells with the perforin-1 inhibitor SN34960, starting on day 1 after infection. Here, PRF1 is linked to hepatitis A virus infection.